Atea Pharmaceuticals AVIR
NASDAQ AVIR
$4.08 -0.39 (-8.62%)
At close: Oct 21, 2026 · 4:00 PM EDT

Atea Pharmaceuticals (AVIR) EBIT Margin (2021)

Updated

Atea Pharmaceuticals (AVIR) recorded EBIT Margin of 63.06% in Q4 2021, up 130.55 percentage points from the prior quarter.

Analysis

Atea Pharmaceuticals (AVIR) EBIT Margin (2021) Analysis & Trends

For FY2021, Atea Pharmaceuticals reported EBIT Margin of 39.38%, up 62.06 percentage points from FY2020.

  • Across earlier years, EBIT Margin came in at -22.68% in FY2020.
  • Per Business Quant, the preceding three quarters came in at -67.50% (Q3 2021), 14.38% (Q2 2021) and 46.46% (Q1 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 28.21%
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 37.86%
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -3.52%
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 32.97%
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 20.57%
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 34.95%
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -133.21%
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 28.37%
10 Atea Pharmaceuticals 325.41 Mn -781.20 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 63.06%
Sep 30, 2021 -67.50%
Jun 30, 2021 14.38%
Mar 31, 2021 46.46%
API Access

Atea Pharmaceuticals EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=AVIR&period=max&api_key=YOUR_API_KEY